AA Multiple randomized trials or meta-analyses, consistent results. How we grade →Meta-analysis of RCTs · 10 RCTs, 77,917 people
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals
T Aung, J Halsey, D Kromhout, H Gerstein, R Marchioli, L Tavazzi et al. JAMA Cardiology. 2018.
Bottom line: Across 10 large trials in high-risk adults, omega-3 supplements did not significantly reduce coronary deaths, heart attacks or major vascular events.
- In plain language
- This meta-analysis pooled 10 large randomized trials, each with at least 500 participants and at least 1 year of treatment, for a total of 77,917 high-risk people with a mean age of 64 who were followed for a mean of 4.4 years. Omega-3 supplements, with EPA doses from 226 to 1,800 mg a day, had no significant link to coronary heart disease death (rate ratio 0.93), nonfatal heart attack (0.97) or major vascular events (0.97). Results were the same in every subgroup, including people with prior coronary heart disease or diabetes and people taking statins.
- Limits
- It predates the REDUCE-IT, STRENGTH and VITAL results, and most trials used doses of 1 g or less. The analysis used study-level data, not individual patient data.
- Which of our grades it feeds
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Science summary: Omega-3: what the largest trials did and did not show
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Omega-3: triglycerides, heart outcomes and why the big trials differ
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Ratings card: Omega-3 (EPA and DHA): Overall omega-3 evidence (claim rows: EPA and DHA status A, triglycerides B)
- Source
- doi.org/10.1001/jamacardio.2017.5205 · PubMed 29387889 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. Reviewed . We sell some of what we grade.